CoChat
Sign Up
Cited by 105

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Defective Transcytosis of APP and Lipoproteins in Human iPSC-Derived Neurons with Familial Alzheimer’s Disease Mutations

Woodruff, Grace, Reyna, Sol M., Dunlap, Mariah, Van Der Kant, Rik, Callender, Julia A., Young, Jessica E., Roberts, Elizabeth A., Goldstein, Lawrence S.B.·2016·Cell Reports
DOI 10.1016/j.celrep.2016.09.034PMC PMC5796664
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2016.09.034

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 57

  1. 2014, 2014 Alzheimer’s disease facts and figures, Alzheimers Dement, 10, e47
  2. Anderson, 2005, Transcytosis of NgCAM in epithelial cells reflects differential signal recognition on the endocytic and secretory pathways, J. Cell Biol., 170, 595, 10.1083/jcb.200506051 · DOI
  3. Ascaño, 2009, Axonal targeting of Trk receptors via transcytosis regulates sensitivity to neurotrophin responses, J. Neurosci., 29, 11674, 10.1523/JNEUROSCI.1542-09.2009 · DOI
  4. Barres, 2001, Cholesterol—making or breaking the synapse, Science, 294, 1296, 10.1126/science.1066724 · DOI
  5. Buggia-Prévot, 2014, Axonal BACE1 dynamics and targeting in hippocampal neurons: a role for Rab11 GTPase, Mol. Neurodegener., 9, 1, 10.1186/1750-1326-9-1 · DOI
  6. Burns, 2003, Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo, J. Neurosci., 23, 5645, 10.1523/JNEUROSCI.23-13-05645.2003 · DOI
  7. Cai, 2003, Presenilin-1 regulates intracellular trafficking and cell surface delivery of β-amyloid precursor protein, J. Biol. Chem., 278, 3446, 10.1074/jbc.M209065200 · DOI
  8. Cataldo, 2000, Endocytic pathway abnormalities precede amyloid β deposition in sporadic Alzheimer’s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations, Am. J. Pathol., 157, 277, 10.1016/S0002-9440(10)64538-5 · DOI · Paper page
  9. Cataldo, 2001, Endocytic disturbances distinguish among subtypes of Alzheimer’s disease and related disorders, Ann. Neurol., 50, 661, 10.1002/ana.1254 · DOI · Paper page
  10. Chang, 2005, Pathophysiological roles of amyloidogenic carboxy-terminal fragments of the beta-amyloid precursor protein in Alzheimer’s disease, J. Pharmacol. Sci., 97, 461, 10.1254/jphs.CR0050014 · DOI
  11. Chen, 2010, ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling, Proc. Natl. Acad. Sci. USA, 107, 12011, 10.1073/pnas.0914984107 · DOI · Paper page
  12. Coen, 2012, Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells, J. Cell Biol., 198, 23, 10.1083/jcb.201201076 · DOI · Paper page
  13. Dumanchin, 1999, Presenilins interact with Rab11, a small GTPase involved in the regulation of vesicular transport, Hum. Mol. Genet., 8, 1263, 10.1093/hmg/8.7.1263 · DOI · Paper page
  14. Fonseca, 2010, Cholesterol and statins in Alzheimer’s disease: current controversies, Exp. Neurol., 223, 282, 10.1016/j.expneurol.2009.09.013 · DOI · Paper page
  15. Gandy, 2007, Alzheimer’s presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo, J. Neurochem., 102, 619, 10.1111/j.1471-4159.2007.04587.x · DOI
  16. Gatz, 2006, Role of genes and environments for explaining Alzheimer disease, Arch. Gen. Psychiatry, 63, 168, 10.1001/archpsyc.63.2.168 · DOI · Paper page
  17. Ginsberg, 2010, Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer’s disease progression, Biol. Psychiatry, 68, 885, 10.1016/j.biopsych.2010.05.030 · DOI · Paper page
  18. Guo, 2012, Amyloid precursor protein revisited: neuron-specific expression and highly stable nature of soluble derivatives, J. Biol. Chem., 287, 2437, 10.1074/jbc.M111.315051 · DOI
  19. Karch, 2015, Alzheimer’s disease risk genes and mechanisms of disease pathogenesis, Biol. Psychiatry, 77, 43, 10.1016/j.biopsych.2014.05.006 · DOI · Paper page
  20. Kim, 2015, Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer’s disease, Mol. Psychiatry, 21, 1
  21. Kounnas, 1995, LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation, Cell, 82, 331, 10.1016/0092-8674(95)90320-8 · DOI · Paper page
  22. Lazo, 2013, BDNF regulates Rab11-mediated recycling endosome dynamics to induce dendritic branching, J. Neurosci., 33, 6112, 10.1523/JNEUROSCI.4630-12.2013 · DOI · Paper page
  23. Lee, 2010, Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations, Cell, 141, 1146, 10.1016/j.cell.2010.05.008 · DOI · Paper page
  24. Lee, 2015, Presenilin 1 maintains lysosomal Ca2+ homeostasis via TRPML1 by regulating vATPase-mediated lysosome acidification, Cell Rep., 12, 1430, 10.1016/j.celrep.2015.07.050 · DOI · Paper page
  25. Leem, 2002, A role for presenilin 1 in regulating the delivery of amyloid precursor protein to the cell surface, Neurobiol. Dis., 11, 64, 10.1006/nbdi.2002.0546 · DOI
  26. Liu, 2013, Apolipoprotein E and Alzheimer disease: risk, mechanisms, and therapy, Nat. Rev, Neurol., 9, 106, 10.1038/nrneurol.2012.263 · DOI · Paper page
  27. Mauch, 2001, CNS synaptogenesis promoted by glia-derived cholesterol, Science, 294, 1354, 10.1126/science.294.5545.1354 · DOI · Paper page
  28. Maxfield, 2014, Role of endosomes and lysosomes in human disease, Cold Spring Harb. Perspect. Biol., 6, a016931, 10.1101/cshperspect.a016931 · DOI
  29. McBrayer, 2013, Lysosome and calcium dysregulation in Alzheimer’s disease: partners in crime, Biochem. Soc. Trans., 41, 1495, 10.1042/BST20130201 · DOI
  30. Nägler, 2001, Glia-derived signals induce synapse formation in neurones of the rat central nervous system, J. Physiol., 533, 665, 10.1111/j.1469-7793.2001.00665.x · DOI
  31. Neely, 2011, Presenilin is necessary for efficient proteolysis through the autophagy-lysosome system in a γ-secretase-independent manner, J. Neurosci., 31, 2781, 10.1523/JNEUROSCI.5156-10.2010 · DOI · Paper page
  32. Niederst, 2015, Axonal amyloid precursor protein and its fragments undergo somatodendritic endocytosis and processing, Mol. Biol. Cell, 26, 205, 10.1091/mbc.E14-06-1049 · DOI · Paper page
  33. Nixon, 2011, Autophagy failure in Alzheimer’s disease--locating the primary defect, Neurobiol. Dis., 43, 38, 10.1016/j.nbd.2011.01.021 · DOI · Paper page
  34. Peric, 2015, Early etiology of Alzheimer’s disease: tipping the balance toward autophagy or endosomal dysfunction?, Acta Neuropathol., 129, 363, 10.1007/s00401-014-1379-7 · DOI
  35. Pfrieger, 2003, Role of cholesterol in synapse formation and function. Biochim, Biophys. Acta, 1610, 271, 10.1016/S0005-2736(03)00024-5 · DOI · Paper page
  36. Pierrot, 2013, Amyloid precursor protein controls cholesterol turnover needed for neuronal activity, EMBO Mol. Med., 5, 608, 10.1002/emmm.201202215 · DOI
  37. Sakane, 2010, LRP6 is internalized by Dkk1 to suppress its phosphorylation in the lipid raft and is recycled for reuse, J. Cell Sci., 123, 360, 10.1242/jcs.058008 · DOI
  38. Selfridge, 2015, Rat embryonic hippocampus and induced pluripotent stem cell derived cultured neurons recover from laser-induced subaxotomy, Neurophotonics, 2, 015006, 10.1117/1.NPh.2.1.015006 · DOI
  39. Sinha, 1999, Cellular mechanisms of beta-amyloid production and secretion, Proc. Natl. Acad. Sci. USA, 96, 11049, 10.1073/pnas.96.20.11049 · DOI
  40. Spires-Jones, 2014, The intersection of amyloid beta and tau at synapses in Alzheimer’s disease, Neuron, 82, 756, 10.1016/j.neuron.2014.05.004 · DOI · Paper page
  41. Svennerholm, 1994, Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II), J. Neurochem., 62, 1039, 10.1046/j.1471-4159.1994.62031039.x · DOI
  42. Szpankowski, 2012, Subpixel colocalization reveals amyloid precursor protein-dependent kinesin-1 and dynein association with axonal vesicles, Proc. Natl. Acad. Sci. USA, 109, 8582, 10.1073/pnas.1120510109 · DOI
  43. Takahashi, 2007, Cholesterol controls lipid endocytosis through Rab11, Mol. Biol. Cell, 18, 2667, 10.1091/mbc.e06-10-0924 · DOI
  44. Tamboli, 2008, Loss of gamma-secretase function impairs endocytosis of lipoprotein particles and membrane cholesterol homeostasis, J. Neurosci., 28, 12097, 10.1523/JNEUROSCI.2635-08.2008 · DOI · Paper page
  45. Taylor, 2005, A microfluidic culture platform for CNS axonal injury, regeneration and transport, Nat. Methods, 2, 599, 10.1038/nmeth777 · DOI
  46. Toyn, 2014, Interpreting Alzheimer’s disease clinical trials in light of the effects on amyloid-β, Alzheimers Res. Ther., 6, 14, 10.1186/alzrt244 · DOI
  47. Udayar, 2013, A paired RNAi and RabGAP overexpression screen identifies Rab11 as a regulator of β-amyloid production, Cell Rep., 5, 1536, 10.1016/j.celrep.2013.12.005 · DOI · Paper page
  48. Ullrich, 1996, Rab11 regulates recycling through the pericentriolar recycling endosome, J. Cell Biol., 135, 913, 10.1083/jcb.135.4.913 · DOI · Paper page
  49. von Bartheld, 2004, Axonal transport and neuronal transcytosis of trophic factors, tracers, and pathogens, J. Neurobiol., 58, 295, 10.1002/neu.10315 · DOI
  50. Weissmiller, 2015, A γ-secretase inhibitor, but not a γ-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP, PLoS ONE, 10, e0118379, 10.1371/journal.pone.0118379 · DOI
  51. Welz, 2014, Orchestration of cell surface proteins by Rab11, Trends Cell Biol., 24, 407, 10.1016/j.tcb.2014.02.004 · DOI
  52. Wilson, 2000, EEA1, a tethering protein of the early sorting endosome, shows a polarized distribution in hippocampal neurons, epithelial cells, and fibroblasts, Mol. Biol. Cell, 11, 2657, 10.1091/mbc.11.8.2657 · DOI
  53. Wolozin, 2004, Cholesterol and the biology of Alzheimer’s disease, Neuron, 41, 7, 10.1016/S0896-6273(03)00840-7 · DOI · Paper page
  54. Woodruff, 2013, The presenilin-1 ΔE9 mutation results in reduced γ-secretase activity, but not total loss of PS1 function, in isogenic human stem cells, Cell Rep., 5, 974, 10.1016/j.celrep.2013.10.018 · DOI · Paper page
  55. Yamakawa, 2010, β-Secretase inhibitor potency is decreased by aberrant β-cleavage location of the “Swedish Mutant” amyloid precursor protein, J Biol Chem., 285, 1634, 10.1074/jbc.M109.066753 · DOI
  56. Yap, 2008, The somatodendritic endosomal regulator NEEP21 facilitates axonal targeting of L1/NgCAM, J. Cell Biol., 180, 827, 10.1083/jcb.200707143 · DOI
  57. Zhang, 2006, Presenilin/gamma-secretase activity regulates protein clearance from the endocytic recycling compartment, FASEB J., 20, 1176, 10.1096/fj.05-5531fje · DOI

Cited by

Sorted by citations

Metadata

Authors
Woodruff, G., Reyna, S. M., Dunlap, M., Van Der Kant, R., Callender, J. A., Young, J. E., Roberts, E. A., & Goldstein, L. S. B.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2016-10
Volume
17
Issue
3
Pages
759-773
ISSN
2211-1247
DOI
10.1016/j.celrep.2016.09.034
PMC
PMC5796664
Cited by
105
References
10
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review